Thalidomide for prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation

OBJECTIVES: The study evaluated the efficacy of thalidomide in prevention of camrelizumab‐induced reactive cutaneous capillary endothelial proliferation (RCCEP). METHODS: In this study, patients treated with camrelizumab plus thalidomide or camrelizumab alone were included. The occurrences, onset ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Geng, Zhang, Fei‐Fei, Cheng, Huai‐Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313837/
https://www.ncbi.nlm.nih.gov/pubmed/35229882
http://dx.doi.org/10.1111/ajd.13812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313837/
https://www.ncbi.nlm.nih.gov/pubmed/35229882
http://dx.doi.org/10.1111/ajd.13812

Ejemplares similares